2.7 A HEALTH ECONOMIC EVALUATION ON THE COST EFFECTIVENESS OF HYPERTENSION MANAGEMENT GUIDED BY CENTRAL BLOOD PRESSURE MEASUREMENT: ANALYSIS OF THE BPGUIDE STUDY
- DOI
- 10.1016/j.artres.2013.10.013How to use a DOI?
- Abstract
Objectives. The BPGUIDE study was a prospective, blinded-endpoint study in 286 hypertensive patients randomised to treatment decisions guided by best-practice usual care (n = 142) or in addition by central BP measurement (n = 144; using SphygmoCor) over twelve months. This study aimed to undertake a health economic assessment to determine cost-effectiveness of hypertension management guided by central BP.
Methods. The primary finding of BPGUIDE was that significantly (p < 0.001) less antihypertensive medication was used to achieve BP control in patients randomised to central BP guided care.The savings from these reductions in medications were used to determine the cost-effective fee for service and this amount was then compared to the actual financial cost of central BP measurement in order to gauge financial viability.
Results. Decreases in 5 antihypertensive medication classes over time were used to calculate financial savings using the Australian Government’s Pharmaceutical Benefits Scheme dollar costs. Savings from less use of medications was calculated at $28 to $32/person (each 3 months) using a capital base cost of $10,000 (for the SphygmoCor device), 5 years capital life, 5% discount rate, patient throughput of 50/year and, labour costs up to $250/hour. Therefore, a fee for service to measure central BP of approximately $30 could be both economically and financially justifiable.
Conclusions. Management of hypertension using central BP has cost-savings relating to decreased medication and may be regarded as cost-neutral when factoring in a fee for central BP measurement.
- Open Access
- This is an open access article distributed under the CC BY-NC license.
Cite this article
TY - JOUR AU - S.P. O’Malley AU - J.E. Sharman PY - 2013 DA - 2013/11/11 TI - 2.7 A HEALTH ECONOMIC EVALUATION ON THE COST EFFECTIVENESS OF HYPERTENSION MANAGEMENT GUIDED BY CENTRAL BLOOD PRESSURE MEASUREMENT: ANALYSIS OF THE BPGUIDE STUDY JO - Artery Research SP - 164 EP - 165 VL - 7 IS - 3-4 SN - 1876-4401 UR - https://doi.org/10.1016/j.artres.2013.10.013 DO - 10.1016/j.artres.2013.10.013 ID - O’Malley2013 ER -